Intensity Therapeutics, Inc.
INTS
$3.67
-$0.07-1.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.66% | 27.82% | 16.56% | -8.74% | -54.37% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.66% | -9.51% | -2.24% | -46.69% | -17.28% |
| Change in Net Operating Assets | 116.52% | -454.24% | 53.08% | 83.41% | -231.91% |
| Cash from Operations | 39.34% | 29.62% | 24.31% | -20.37% | -111.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 211.95% | 211.98% | 205.50% |
| Cash from Investing | -- | -100.00% | 211.95% | 211.98% | 205.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 473.60% | 2,984.39% | -61.92% | -82.70% | -84.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -178.10% | -2,121.95% | 17.96% | 70.00% | 70.76% |
| Cash from Financing | 540.14% | 3,254.01% | -66.08% | -84.12% | -85.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 256.40% | 209.53% | -133.01% | -195.43% | -182.36% |